Ondine Biomedical Inc. (AIM: OBI) announces that one of Canada's top research hospitals, The Ottawa Hospital, has presented results from its 2022 quality improvement study into patient outcomes after spinal surgery when using the Company's SteriwaveTM nasal photodisinfection for the prevention of surgical site infections ('SSIs').

The study results were presented for the first time at the 2023 Annual Scientific Conference of the Canadian Spine Society in Quebec on Thursday 2 March, 2023.

The podium presentation showed that spine surgery patients treated with Ondine Biomedical's Steriwave nasal photodisinfection had a 48% shorter mean length of stay in hospital compared with those not treated (LOS: 5.58 days vs. 10.67, P

(C) 2023 Electronic News Publishing, source ENP Newswire